Abstract
Anemia is a predictor of poor prognosis in chronic heart failure (CHF). Treatment of anemia with erythropoiesis-stimulating agent has been expected to improve prognosis, but darbepoetin-alfa failed to improve it in CHF patients. Thus, other treatment options for anemia are needed in CHF. Chinese medicine Juzen-taiho-to (JTT) has been known to improve anemia. We examined whether JTT would improve anemia in the Dahl salt-sensitive (DS) rat, a model of hypertensive CHF.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.